Subscribe


PD breaking news – EBOS reports NZ$53.9m profit

Strong first half for EBOS with Australian business up 10%. 

EBOS has just released its results for the six months to 31 December, with the local operations reporting a 10.1% increase in EBITDA. There were strong contributions across the board, with “sound growth” in Institutional Healthcare, Consumer Products and the Pharmacy businesses.The net profit after tax was NZ$53.9 million for the group.

CEO Patrick Davies said total group revenues were up 4% to NZ$3.1 billion, while the Australian healthcare business grew 6.5% to NZ$2.285 billion. Of particular note was the 25% acquisition of Good Price Pharmacy Warehouse during the period, which had seen strong levels of wholesale conversion resulting in increased sales for the Symbion wholesale business.

During the half EBOS also opened its new pharmacy distribution facility in Keysborough, Melbourne, representing a capital investment of $31 million, which Davies said reflected the company’s long term commitment to the industry.

“Our business model continues to drive the profitable development of the group and is allowing us to continue to pursue opportunities for the benefit of our customers and shareholders,” Davies said.

More information in today’s issue of Pharmacy Daily.

 


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

23 Jan

Guild Update 23 Jan 18 - WITH just over a week to go ...


23 Jan

Dispensary Corner 23 Jan 18 - KEEPING kids who suffer from conditions such ...


23 Jan

NZSMI blasts NZ codeine upschedule - ...


23 Jan

Pharmacy BP clinics - THE role community pharmacies can play in ...


23 Jan

Zantac discount deal - ASPEN Australia is promoting a special "double ...


23 Jan

Not-so-smart thief - A woman has been sentenced in the ...


23 Jan

February epidemic asthma surge - THE National Asthma Council Australia is urging ...


23 Jan

New GSK APAC chief - GSK Consumer Healthcare has appointed Filippo Lanzi ...


23 Jan

Pharmacists and AMR - PHARMACISTS are an "underutilised resource for Antimicrobial ...


23 Jan

Adherence Perx - SYDNEY start-up Perx Health, with the support ...


23 Jan

FDA recall guidance - THE U.S. Food and Drug Administration (FDA) ...


23 Jan

TGA extends tender - THE TGA has extended the lodgement date ...


23 Jan

CMA blasts ‘fringe’ groups - COMPLEMENTARY Medicines Australia (CMA) has criticised Friends ...


23 Jan

Dose Innovations administration - EXTERNAL administrators have been appointed to Brisbane-based ...


22 Jan

Weekly Comment 22 Jan 18 - WELCOME to PD's weekly comment feature. This ...


22 Jan

Dispensary Corner 22 Jan 18 - MEDICINAL marijuana is the subject of several ...


22 Jan

FDA pings Delta Labs - THE US Food and Drug Administration (FDA) ...


22 Jan

S3 ad clarification - THE Therapeutic Goods Administration has stressed that ...


22 Jan

Opioid consultation - OPTIONS for a regulatory response to opioid ...


22 Jan

Metformin recall - APOTEX is recallilng one patch of APO-Metformin ...



Show Pharmacy Daily items by month: